Biography

Andrew serves as a portfolio manager at Marshall Wace, a leading asset management firm, where he helps lead the XO Healthcare Innovation Fund. Before this, and since February 2016, he served as a partner on the innovation team at Vivo Capital, a global healthcare investment firm focused exclusively on the life sciences industry. Prior to this, Andrew was a consultant at McKinsey & Company, where he served pharmaceutical, medical device and biotechnology companies across a range of strategy, M&A, sales, marketing and product development topics. Andrew is a US board-certified physician in both critical care and emergency medicine. He served as an instructor in medicine at the Mayo Clinic College of Medicine in Rochester, MN, from January 2013 to June 2013, where he also completed a fellowship in critical care medicine and served as an attending physician in the Department of Emergency Medicine. Prior to this, Andrew completed emergency medicine residency training at the Los Angeles County + University of Southern California Medical Center (LAC+USC). Andrew has contributed to more than 25 scientific publications in leading peer-reviewed journals, including JAMA, Resuscitation and the Cleveland Clinic Journal of Medicine and his research spans a variety of topics, from traumatic brain injury and cardiac arrest to biomarker analysis and healthcare quality.

Andrew received his MD from The George Washington University School of Medicine in Washington, DC, and a postdoctoral diploma in translational science from the Mayo Clinic Graduate School of Biomedical Sciences. He has held academic and clinical appointments at Oregon Health & Science University, the University of Arizona, the Washington Township Medical Foundation and the Banner Health System.